New Gender Affirming Care Resource

Sexual Health Infolink (NSW Ministry of Health), 2019

As more services are beginning to provide hormonal therapies to trans and gender diverse people, the NSW Sexual Health Infolink (SHIL) has consolidated the key resources to guide best practice.

Bookmark SHIL’s Gender Affirming Care page for quick access to:

  • Clinical guidelines and patient fact sheets about hormonal therapies,
  • Specialist trans and gender diverse clinical services,
  • Counselling and peer support services,
  • Information and resources for family and friends.

The Sexual Health Infolink is a NSW Ministry of Health funded telephone and internet based information and referral service. It has been operating since 1989 and is staffed by specialist sexual health nurses.

Trans @ Work: a guide for trans employees, their employers, and colleagues

Queensland Human Rights Commission, 2019

This information is for trans and gender diverse employees, their employers, managers and colleagues who are seeking guidance on issues associated with transitioning at work.

The guidelines suggest ways to:

  • work together the achieve a successful transition in the workplace;
  • address pre-employment issues; and
  • provide ongoing support to trans employees.

Why is a trans inclusive workplace important?

For the employee:

  • staying in employment;
  • maintaining self-respect;
  • having financial security.

For the employer:

  • improving staff satisfaction and retention through modern, inclusive workplace policies;
  • enhancing public image of the organisation;
  • reaching new client groups;
  • improving teamwork and increasing productivity;
  • complying with state and federal discrimination legislation

The document also contains some real-life stories.

HIV and Trans Women: A Literature Review

Transgend Health. 2018; 3(1): 239–250

Abstract:

Trans women are a key, yet under-researched, population in the HIV epidemic. However, there remains a paucity of data on the health and wellbeing of trans women at risk of, or living with, HIV in the United Kingdom.

This article provides a narrative review of key empirical research into HIV among trans women. In an effort to explore individual and social factors in relation to HIV in this population, we outline key tenets of identity process theory from social psychology and the concept of structural violence from medical anthropology.

We focus on published studies around the following themes: (1) epidemiological data, (2) syndemic factors (3) barriers to social support, (4) HIV and gender transitioning, and (5) access to and engagement with health care.

We identify lacunae and thus call for United Kingdom-based research in the following areas: (1) the prevalence and incidence of HIV in trans women, (2) the impact of syndemic factors on HIV risk and acquisition in trans women, (3) the nature of social support for coping with syndemic factors, (4) the interface of gender transitioning and HIV, and (5) barriers to accessing HIV prevention and care services.

There is great scope (and urgency) for research into HIV among trans women, especially in the United Kingdom, to reduce incidence in this group, to enhance engagement in HIV care across the care continuum, and to improve the health and wellbeing of those living with HIV. A tentative model for HIV prevention and care is presented in this article.

Transgender women taking PrEP have lower levels of PrEP drugs than cisgender men

aidsmap/nam, November 9th 2018

A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells about 40% lower. Tenofovir levels in rectal tissue were 44% lower.

However, the study also confirmed that the interaction between hormones and PrEP did not appear to go the other way; blood levels of estradiol, the one hormone all of the transgender women took in one form or another, do not appear to be affected by PrEP.

 

National LGBT Survey: Research report [UK]

Government Equalities Office, July 2018

The Government Equalities Office launched a national LGBT survey in July 2017 in order to develop a better understanding of the lived experiences of lesbian, gay, bisexual and transgender people, and people who identify as having any other minority sexual orientation or gender identity, or as intersex.

The survey was open for 12 weeks and received 108,100 valid responses through an
anonymous online questionnaire that collected the experiences and views of
individuals who self-identified as having a minority sexual orientation or gender
identity, or as intersex, and were aged 16 or above and living in the UK. The survey placed an emphasis on issues relating to personal safety, education, the
workplace and healthcare. These were selected because existing evidence on the
experiences of LGBT people and their life outcomes tells us that these are the main
areas in which inequalities exist.

 

 

Using Chosen Names Reduces Odds of Depression and Suicide in Transgender Youths

The University of Texas at Austin, Tue, April 3, 2018

In one of the largest and most diverse studies of transgender youths to date, researchers led by a team at The University of Texas at Austin have found that when transgender youths are allowed to use their chosen name in places such as work, school and at home, their risk of depression and suicide drops.     

“Many kids who are transgender have chosen a name that is different than the one that they were given at birth,” said author Stephen T. Russell, professor and chair of human development and family science. “We showed that the more contexts or settings where they were able to use their preferred name, the stronger their mental health was.”